The pulmonary surgical Apgar score for lung cancer surgery predicts postoperative complications and long-term survival.

Lung cancer surgery Postoperative complications Prognostic factor Pulmonary surgical Apgar score Surgical Apgar score

Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
03 04 2023
Historique:
received: 31 08 2022
revised: 29 12 2022
accepted: 03 02 2023
medline: 17 4 2023
pubmed: 7 2 2023
entrez: 6 2 2023
Statut: ppublish

Résumé

The surgical Apgar score, calculated using 3 intraoperative variables (blood loss, lowest mean arterial pressure and lowest heart rate), is associated with mortality in cancer surgery. The original score has less applicability in lung cancer surgery; therefore, we innovated the modified pulmonary surgical Apgar score with additional intraoperative oxygen saturation representing pulmonary parenchymal damage and cardiopulmonary dynamics. We retrospectively analysed the data of 691 patients who underwent surgery for primary lung cancer between 2015 and 2019 at a single institute. We analysed the utility of the pulmonary surgical Apgar score compared with the original surgical Apgar score. Postoperative complications were observed in 57 (8.2%) and 7 (1.0%) of the 691 patients who were stratified as grade ≥III and V, respectively, according to the Clavien-Dindo classification. We compared the fitness of the score in predicting postoperative complications; the calculated c-index (0.622) was slightly higher than the original c-index (0.604; P = 0.398). Patients were categorized into 3 groups based on their scores as follows: 0-6 points (n = 59), 7-9 points (n = 420) and 10-12 points (n = 212). Univariable and multivariable analyses demonstrated that a lower score was an independent negative risk factor for postoperative complications (odds ratio 3.53; P = 0.02). Patients with lower scores had a considerably poor 5-year overall survival (64.6%) (P = 0.07). The pulmonary surgical Apgar score predicts postoperative complications and long-term survival in patients with lung cancer undergoing surgery and may be utilized for postoperative management.

Identifiants

pubmed: 36744937
pii: 7028490
doi: 10.1093/ejcts/ezad036
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Haruaki Hino (H)

Department of Thoracic Surgery, Kansai Medical University, Osaka, Japan.

Satoshi Hagihira (S)

Department of Anesthesiology, Kansai Medical University, Osaka, Japan.

Natsumi Maru (N)

Department of Thoracic Surgery, Kansai Medical University, Osaka, Japan.

Takahiro Utsumi (T)

Department of Thoracic Surgery, Kansai Medical University, Osaka, Japan.

Hiroshi Matsui (H)

Department of Thoracic Surgery, Kansai Medical University, Osaka, Japan.

Yohei Taniguchi (Y)

Department of Thoracic Surgery, Kansai Medical University, Osaka, Japan.

Tomohito Saito (T)

Department of Thoracic Surgery, Kansai Medical University, Osaka, Japan.

Tomohiro Murakawa (T)

Department of Thoracic Surgery, Kansai Medical University, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH